Albireo Pharma, Inc.
Albireo Pharma, Inc.（ALBO）内幕交易
基于 SEC Form 4 的买入/卖出笔数、买卖比与情绪标签；可在本季度与近12个月之间切换；下方为季度图与交易明细。
SEC EDGAR · FMP · ALBO · 截至 2026年6月9日
活动摘要
买入笔数
0
P-Purchase only
卖出笔数
52
近12个月
买卖比
0.00
Buy/Sell (by trades)
整体情绪
Albireo Pharma, Inc.内部人在过去近12个月主要在卖出股份，卖出行为通常由预设的Rule 10b5-1计划驱动，不一定代表对公司的负面看法。
▸ 数据来源：SEC EDGAR · Form 3 & 4 · 买入仅计P-Purchase · 卖出仅计S-Sale
截至 2026年6月9日
ALBO 季度内部人买卖趋势
ALBO 内幕交易卖出 · ALBO 内幕交易买入 · 季度活动
Mobile shows last 4Q · Desktop shows full 8Q
▸ 数据来源：SEC EDGAR · Form 3 & 4 · 最近8季度
As of Jun 9, 2026
近期内幕交易记录
ALBO 高管卖出股份 · ALBO 董事内幕交易 · SEC Form 4申报
横向滑动查看全部列
| 日期 | 内部人 | 类型 | 股数 | 总金额 | 申报 |
|---|---|---|---|---|---|
| Mar 2, 2023 | Chiswell David Director | Other | 56,278 | $563K | Form 4 |
| Mar 2, 2023 | Harford Simon N.R. CFO and Treasurer | Other | 13,739 | $137K | Form 4 |
| Mar 2, 2023 | Cooper Ronald Harold Wilfred President and CEO · Director | Other | 33,094 | $331K | Form 4 |
| Mar 2, 2023 | Stephenson Pamela Chief Commercial Officer | Other | 22,242 | $222K | Form 4 |
| Mar 2, 2023 | Graham Michelle Chief Human Resources Officer | Other | 5,543 | $55K | Form 4 |
| Mar 2, 2023 | Carter Martha J. Chief Regulatory Officer | Other | 3,656 | $37K | Form 4 |
| Mar 2, 2023 | Duncan Jason Chief Legal Officer and GC | Other | 3,296 | $33K | Form 4 |
| Mar 2, 2023 | Mattsson Jan Chief Scientific Officer | Other | 35,524 | $355K | Form 4 |
| Jan 19, 2023 | Cooper Ronald Harold Wilfred President and CEO | Award | 195,000 | — | Form 4 |
| Jan 19, 2023 | Mattsson Jan Chief Scientific Officer | Award | 55,000 | — | Form 4 |
| Jan 19, 2023 | Duncan Jason Chief Legal Officer and GC | Award | 55,000 | — | Form 4 |
| Jan 19, 2023 | STRECK PAUL Chief Medical Officer | Award | 55,000 | — | Form 4 |
| Jan 23, 2023 | Stephenson Pamela Chief Commercial Officer | Sale | 102 | $4K | Form 4 |
| Jan 23, 2023 | Graham Michelle Chief Human Resources Officer | Sale | 102 | $4K | Form 4 |
| Jan 23, 2023 | Mattsson Jan Chief Scientific Officer | Sale | 197 | $9K | Form 4 |
| Jan 23, 2023 | Harford Simon N.R. CFO and Treasurer | Sale | 102 | $4K | Form 4 |
| Jan 23, 2023 | Duncan Jason Chief Legal Officer and GC | Sale | 228 | $10K | Form 4 |
| Jan 23, 2023 | Cooper Ronald Harold Wilfred President and CEO | Sale | 1,057 | $46K | Form 4 |
| Jan 23, 2023 | Carter Martha J. Chief Regulatory Officer | Sale | 120 | $5K | Form 4 |
Cooper Ronald Harold Wilfred
President and CEO · Director
日期
Mar 2
股数
33,094
均价
$10.00
总金额
$331K
Graham Michelle
Chief Human Resources Officer
日期
Mar 2
股数
5,543
均价
$10.00
总金额
$55K
Cooper Ronald Harold Wilfred
President and CEO
日期
Jan 23
股数
1,057
均价
$43.80
总金额
$46K
▸ 数据来源：SEC EDGAR · Form 4 申报 · ⚡ = 金额≥$100万 · Award/Option 价格显示 —
关于 ALBO 内幕交易
ALBO 内幕交易
Albireo Pharma, Inc.（ALBO）内幕交易数据来源于公司内部人（包括ALBO）提交的SEC Form 4申报文件。过去12个月内，0位内部人向SEC提交了交易申报。ALBO内部人近期主要在卖出，这可能反映预设的10b5-1计划执行，而非方向性判断。
如需查看Albireo Pharma, Inc.机构持仓比例和内部人持股百分比，请访问持仓（Ownership）标签页 → Ownership tab →
常见问题
ALBO 内幕交易 · 5个问题Albireo Pharma, Inc.（ALBO）的内部人包括高管和董事，如ALBO等。过去12个月内，0位内部人向SEC提交了Form 4交易申报。内部人须在交易日期后2个工作日内完成申报。
▸ 数据来源：FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · RSU归属不计入情绪 · As of Jun 9, 2026